Primary breast angiosarcoma: A case report

BackgroundPrimary breast angiosarcoma (PBA) is a rare sarcoma, accounting for only 0.04% of all breast malignancies, with a difficult diagnosis and a poor prognosis. Mastectomy is the standard treatment, and the role of adjuvant treatment (chemotherapy and/or radiotherapy following surgery) remains...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in surgery 2022, Vol.9, p.966792-966792
Hauptverfasser: He, Yu, Qian, Liyuan, Chen, Lang, Liu, Yang, Wen, Yanguang, Cao, Peiguo
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 966792
container_issue
container_start_page 966792
container_title Frontiers in surgery
container_volume 9
creator He, Yu
Qian, Liyuan
Chen, Lang
Liu, Yang
Wen, Yanguang
Cao, Peiguo
description BackgroundPrimary breast angiosarcoma (PBA) is a rare sarcoma, accounting for only 0.04% of all breast malignancies, with a difficult diagnosis and a poor prognosis. Mastectomy is the standard treatment, and the role of adjuvant treatment (chemotherapy and/or radiotherapy following surgery) remains uncertain with very few studies. Case PresentationWe report the case of a 17-year-old female patient who presented with a right breast lump that had rapidly increased in size and was hemorrhaging. She was diagnosed with breast angiosarcoma by needle biopsy and pathological evaluation. However, the mass showed a quick tendency to bleed during biopsies. After that, we performed angiography and tumor vascular embolization. The patient underwent a mastectomy followed by adjuvant chemotherapy. ConclusionTumor vascular embolization reduced the surgical risk of PBA with hemorrhage complications. Postoperative therapeutic roles still need further exploration and verification.
doi_str_mv 10.3389/fsurg.2022.966792
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2783790905</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2783790905</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_27837909053</originalsourceid><addsrcrecordid>eNqVyrEOgjAUQNHGaCJRPsCtozERyyu01M0YjaODgxuppBAMUHwPBv_excHV6Z7hMraKRSRlZnYljVhFIAAio5Q2MGEBgFHbTKf36Y_nLCR6CiFimcQKkoBtrli3Ft_8gc7SwG1X1Z4sFr61e37ghSXH0fUehyWblbYhF367YOvz6Xa8bHv0r9HRkLc1Fa5pbOf8SDnoTGojjEjlH-sHnW49SQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2783790905</pqid></control><display><type>report</type><title>Primary breast angiosarcoma: A case report</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>He, Yu ; Qian, Liyuan ; Chen, Lang ; Liu, Yang ; Wen, Yanguang ; Cao, Peiguo</creator><creatorcontrib>He, Yu ; Qian, Liyuan ; Chen, Lang ; Liu, Yang ; Wen, Yanguang ; Cao, Peiguo</creatorcontrib><description>BackgroundPrimary breast angiosarcoma (PBA) is a rare sarcoma, accounting for only 0.04% of all breast malignancies, with a difficult diagnosis and a poor prognosis. Mastectomy is the standard treatment, and the role of adjuvant treatment (chemotherapy and/or radiotherapy following surgery) remains uncertain with very few studies. Case PresentationWe report the case of a 17-year-old female patient who presented with a right breast lump that had rapidly increased in size and was hemorrhaging. She was diagnosed with breast angiosarcoma by needle biopsy and pathological evaluation. However, the mass showed a quick tendency to bleed during biopsies. After that, we performed angiography and tumor vascular embolization. The patient underwent a mastectomy followed by adjuvant chemotherapy. ConclusionTumor vascular embolization reduced the surgical risk of PBA with hemorrhage complications. Postoperative therapeutic roles still need further exploration and verification.</description><identifier>ISSN: 2296-875X</identifier><identifier>EISSN: 2296-875X</identifier><identifier>DOI: 10.3389/fsurg.2022.966792</identifier><language>eng</language><ispartof>Frontiers in surgery, 2022, Vol.9, p.966792-966792</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,860,4476,27902</link.rule.ids></links><search><creatorcontrib>He, Yu</creatorcontrib><creatorcontrib>Qian, Liyuan</creatorcontrib><creatorcontrib>Chen, Lang</creatorcontrib><creatorcontrib>Liu, Yang</creatorcontrib><creatorcontrib>Wen, Yanguang</creatorcontrib><creatorcontrib>Cao, Peiguo</creatorcontrib><title>Primary breast angiosarcoma: A case report</title><title>Frontiers in surgery</title><description>BackgroundPrimary breast angiosarcoma (PBA) is a rare sarcoma, accounting for only 0.04% of all breast malignancies, with a difficult diagnosis and a poor prognosis. Mastectomy is the standard treatment, and the role of adjuvant treatment (chemotherapy and/or radiotherapy following surgery) remains uncertain with very few studies. Case PresentationWe report the case of a 17-year-old female patient who presented with a right breast lump that had rapidly increased in size and was hemorrhaging. She was diagnosed with breast angiosarcoma by needle biopsy and pathological evaluation. However, the mass showed a quick tendency to bleed during biopsies. After that, we performed angiography and tumor vascular embolization. The patient underwent a mastectomy followed by adjuvant chemotherapy. ConclusionTumor vascular embolization reduced the surgical risk of PBA with hemorrhage complications. Postoperative therapeutic roles still need further exploration and verification.</description><issn>2296-875X</issn><issn>2296-875X</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2022</creationdate><recordtype>report</recordtype><recordid>eNqVyrEOgjAUQNHGaCJRPsCtozERyyu01M0YjaODgxuppBAMUHwPBv_excHV6Z7hMraKRSRlZnYljVhFIAAio5Q2MGEBgFHbTKf36Y_nLCR6CiFimcQKkoBtrli3Ft_8gc7SwG1X1Z4sFr61e37ghSXH0fUehyWblbYhF367YOvz6Xa8bHv0r9HRkLc1Fa5pbOf8SDnoTGojjEjlH-sHnW49SQ</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>He, Yu</creator><creator>Qian, Liyuan</creator><creator>Chen, Lang</creator><creator>Liu, Yang</creator><creator>Wen, Yanguang</creator><creator>Cao, Peiguo</creator><scope>7X8</scope></search><sort><creationdate>20220101</creationdate><title>Primary breast angiosarcoma: A case report</title><author>He, Yu ; Qian, Liyuan ; Chen, Lang ; Liu, Yang ; Wen, Yanguang ; Cao, Peiguo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_27837909053</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>He, Yu</creatorcontrib><creatorcontrib>Qian, Liyuan</creatorcontrib><creatorcontrib>Chen, Lang</creatorcontrib><creatorcontrib>Liu, Yang</creatorcontrib><creatorcontrib>Wen, Yanguang</creatorcontrib><creatorcontrib>Cao, Peiguo</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Yu</au><au>Qian, Liyuan</au><au>Chen, Lang</au><au>Liu, Yang</au><au>Wen, Yanguang</au><au>Cao, Peiguo</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Primary breast angiosarcoma: A case report</atitle><jtitle>Frontiers in surgery</jtitle><date>2022-01-01</date><risdate>2022</risdate><volume>9</volume><spage>966792</spage><epage>966792</epage><pages>966792-966792</pages><issn>2296-875X</issn><eissn>2296-875X</eissn><abstract>BackgroundPrimary breast angiosarcoma (PBA) is a rare sarcoma, accounting for only 0.04% of all breast malignancies, with a difficult diagnosis and a poor prognosis. Mastectomy is the standard treatment, and the role of adjuvant treatment (chemotherapy and/or radiotherapy following surgery) remains uncertain with very few studies. Case PresentationWe report the case of a 17-year-old female patient who presented with a right breast lump that had rapidly increased in size and was hemorrhaging. She was diagnosed with breast angiosarcoma by needle biopsy and pathological evaluation. However, the mass showed a quick tendency to bleed during biopsies. After that, we performed angiography and tumor vascular embolization. The patient underwent a mastectomy followed by adjuvant chemotherapy. ConclusionTumor vascular embolization reduced the surgical risk of PBA with hemorrhage complications. Postoperative therapeutic roles still need further exploration and verification.</abstract><doi>10.3389/fsurg.2022.966792</doi></addata></record>
fulltext fulltext
identifier ISSN: 2296-875X
ispartof Frontiers in surgery, 2022, Vol.9, p.966792-966792
issn 2296-875X
2296-875X
language eng
recordid cdi_proquest_miscellaneous_2783790905
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access
title Primary breast angiosarcoma: A case report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A06%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Primary%20breast%20angiosarcoma:%20A%20case%20report&rft.jtitle=Frontiers%20in%20surgery&rft.au=He,%20Yu&rft.date=2022-01-01&rft.volume=9&rft.spage=966792&rft.epage=966792&rft.pages=966792-966792&rft.issn=2296-875X&rft.eissn=2296-875X&rft_id=info:doi/10.3389/fsurg.2022.966792&rft_dat=%3Cproquest%3E2783790905%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2783790905&rft_id=info:pmid/&rfr_iscdi=true